Greenwich LifeSciences
GLSI
#8930
Rank
HK$1.06 B
Marketcap
HK$76.95
Share price
2.91%
Change (1 day)
-26.52%
Change (1 year)

Revenue for Greenwich LifeSciences (GLSI)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Greenwich LifeSciences from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
HK$4.99 BN/A Jersey
Novavax
NVAX
HK$7.97 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
HK$1.12 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
HK$0.16 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK